{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:09:45Z","timestamp":1770145785459,"version":"3.49.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Research of Jiangsu Higher Education institution of China","award":["23KJB320011"],"award-info":[{"award-number":["23KJB320011"]}]},{"name":"Outstanding Young Doctor Training Program of Jiangsu Province Hospital of Chinese Medicine","award":["2023QB0131"],"award-info":[{"award-number":["2023QB0131"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background.<\/jats:bold>\n Interleukin-1 receptor antagonist (IL1RA) blocks the interaction between IL-1 and its receptors. It modulates inflammatory responses, cell proliferation, and the invasion of cancer cells. In this study, we examined the biological functions of IL1RA and the mechanisms that influence its effects on prostate cancer (PCa).\n <\/jats:p>\n \n Materials and methods.<\/jats:bold>\n We performed RT-qPCR and Western blot analyses to evaluate IL1RA expression levels in various cell lines. For functional studies, we employed MTT, colony formation, soft agar, wound healing, and transwell migration and invasion assays. Then, we analyzed Western blots to elucidate the underlying mechanisms involved. Xenograft mouse models were ultimately established after the overexpression of IL1RA.\n <\/jats:p>\n \n Results.<\/jats:bold>\n IL1RA was expressed at higher levels in prostate epithelial cells compared with the PCa cell lines. BPH cells with lower IL1RA expression exhibited an increased cell proliferation. The PCa cell lines C4-2B and LNCap, which overexpressed IL1RA, demonstrated suppressed tumorigenic properties in vitro. The in vivo experiment demonstrated an inhibitory effect on tumor growth in xenograft mice. Furthermore, Western blot results indicated elevated phosphorylated AKT levels in BPH cells with IL1RA knockdown, and phosphorylated AKT and GSK-3\n \n \n \n \n \n \u03b2<\/mml:mi>\n <\/mml:mrow>\n <\/mml:math>\n <\/jats:alternatives>\n <\/jats:inline-formula>\n levels were reduced in C4-2B and LNCap cells that overexpressed IL1RA.\n <\/jats:p>\n \n Conclusion.<\/jats:bold>\n This study revealed that IL1RA low expression is associated with PCa progression. Our finding has great clinical and translational significance. The potential clinical application of IL1RA as a therapeutic target for PCa requires further investigation.\n <\/jats:p>","DOI":"10.1371\/journal.pone.0339611","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T18:43:20Z","timestamp":1770057800000},"page":"e0339611","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Loss of IL1RA promotes prostate cancer growth and metastasis by activating Akt signaling pathway"],"prefix":"10.1371","volume":"21","author":[{"given":"Cheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taoze","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-9355","authenticated-orcid":true,"given":"Mingquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"pone.0339611.ref001","doi-asserted-by":"crossref","first-page":"215927","DOI":"10.1016\/j.canlet.2022.215927","article-title":"Prostate cancer treatment - China\u2019s perspective","volume":"550","author":"J Liu","year":"2022","journal-title":"Cancer Lett."},{"issue":"20","key":"pone.0339611.ref002","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1158\/1078-0432.CCR-15-0242","article-title":"Notch Pathway Inhibition Using PF-03084014, a \u03b3-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer","volume":"21","author":"D Cui","year":"2015","journal-title":"Clin Cancer Res."},{"issue":"1","key":"pone.0339611.ref003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/107327481602300108","article-title":"Racial disparity in time between first diagnosis and initial treatment of prostate cancer","volume":"23","author":"BL Kinlock","year":"2016","journal-title":"Cancer Control."},{"issue":"3","key":"pone.0339611.ref004","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate cancer","volume":"42","author":"K Desai","year":"2021","journal-title":"Endocrine Reviews."},{"issue":"12","key":"pone.0339611.ref005","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-17-0145","article-title":"Androgen deprivation and immunotherapy for the treatment of prostate cancer","volume":"24","author":"M Gamat","year":"2017","journal-title":"Endocr Relat Cancer."},{"issue":"6","key":"pone.0339611.ref006","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1164\/rccm.201403-0586OC","article-title":"A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock","volume":"190","author":"NJ Meyer","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"pone.0339611.ref007","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/jcbfm.2014.23","article-title":"Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial","volume":"34","author":"A Helmy","year":"2014","journal-title":"J Cereb Blood Flow Metab."},{"issue":"1","key":"pone.0339611.ref008","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/s41467-018-04460-w","article-title":"TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis","volume":"9","author":"O Iriondo","year":"2018","journal-title":"Nat Commun."},{"issue":"11","key":"pone.0339611.ref009","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.3390\/ijms22115875","article-title":"The role of Interleukin-1-receptor-antagonist in bladder cancer cell migration and invasion","volume":"22","author":"L Schneider","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"4","key":"pone.0339611.ref010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10147-018-1242-2","article-title":"Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer","volume":"23","author":"Z Gong","year":"2018","journal-title":"Int J Clin Oncol."},{"issue":"6","key":"pone.0339611.ref011","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22903","article-title":"IL-1RA suppresses esophageal cancer cell growth by blocking IL-1\u03b1","volume":"33","author":"S Chen","year":"2019","journal-title":"J Clin Lab Anal."},{"issue":"3","key":"pone.0339611.ref012","first-page":"908","article-title":"Interleukin 1\u03b2\/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy","volume":"43","author":"Y Chen","year":"2020","journal-title":"Oncol Rep."},{"key":"pone.0339611.ref013","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.omtm.2021.12.006","article-title":"Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences","volume":"24","author":"PD Trivedi","year":"2022","journal-title":"Molecular Therapy - Methods & Clinical Development."},{"issue":"12","key":"pone.0339611.ref014","doi-asserted-by":"crossref","first-page":"100141","DOI":"10.1016\/j.mocell.2024.100141","article-title":"Brief guide to RT-qPCR","volume":"47","author":"D Bong","year":"2024","journal-title":"Mol Cells."},{"issue":"1","key":"pone.0339611.ref015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/ijms24010562","article-title":"Interfering with color response by porphyrin-related compounds in the MTT tetrazolium-based colorimetric assay","volume":"24","author":"BH Choi","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"18","key":"pone.0339611.ref016","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1073\/pnas.1505979112","article-title":"Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation","volume":"112","author":"A Rotem","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"pone.0339611.ref017","article-title":"AURKA enhances the glycolysis and development of ovarian endometriosis through ER\u03b2","volume":"165","author":"Y Sun","year":"2024","journal-title":"Endocrinology."},{"issue":"1","key":"pone.0339611.ref018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7150\/thno.21234","article-title":"Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function","volume":"8","author":"Y Hu","year":"2018","journal-title":"Theranostics."},{"issue":"17","key":"pone.0339611.ref019","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.7150\/thno.26789","article-title":"Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma","volume":"8","author":"Z Liu","year":"2018","journal-title":"Theranostics."},{"issue":"22","key":"pone.0339611.ref020","doi-asserted-by":"crossref","first-page":"14283","DOI":"10.3390\/ijms232214283","article-title":"The role of TKS5 in chromosome stability and bladder cancer progression","volume":"23","author":"W Wang","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"11","key":"pone.0339611.ref021","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/bjc.2011.132","article-title":"Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer","volume":"104","author":"EE Vincent","year":"2011","journal-title":"Br J Cancer."},{"key":"pone.0339611.ref022","doi-asserted-by":"crossref","first-page":"102428","DOI":"10.1016\/j.tranon.2025.102428","article-title":"IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type I interferon response","volume":"58","author":"Y Ding","year":"2025","journal-title":"Transl Oncol."},{"issue":"6","key":"pone.0339611.ref023","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00404-007-0504-4","article-title":"Impact of polymorphism in IL-1RA gene on the risk of cervical cancer","volume":"277","author":"DMK Tamandani","year":"2008","journal-title":"Arch Gynecol Obstet."},{"issue":"5","key":"pone.0339611.ref024","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3892\/mco.2017.1195","article-title":"Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer","volume":"6","author":"M Yigit","year":"2017","journal-title":"Mol Clin Oncol."},{"issue":"8","key":"pone.0339611.ref025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.18632\/oncotarget.27941","article-title":"Urine protein biomarkers of bladder cancer arising from 16-plex antibody-based screens","volume":"12","author":"K Vanarsa","year":"2021","journal-title":"Oncotarget."},{"issue":"6","key":"pone.0339611.ref026","first-page":"604","article-title":"Precision medicine: IL-1RA and pancreatic cancer organoids","volume":"14","author":"AG Morgan","year":"2025","journal-title":"Biology (Basel)."},{"issue":"1","key":"pone.0339611.ref027","doi-asserted-by":"crossref","first-page":"1944538","DOI":"10.1080\/2162402X.2021.1944538","article-title":"Impact of IL-1\u03b2 and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance","volume":"10","author":"H Grauers Wiktorin","year":"2021","journal-title":"Oncoimmunology."},{"issue":"12","key":"pone.0339611.ref028","article-title":"Soft agar colony formation assay as a hallmark of carcinogenesis","volume":"7","author":"F Du","year":"2017","journal-title":"Bio Protoc."},{"issue":"9","key":"pone.0339611.ref029","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/cells11091538","article-title":"To detach, migrate, adhere, and metastasize: CD97\/ADGRE5 in cancer","volume":"11","author":"G Aust","year":"2022","journal-title":"Cells."},{"issue":"5","key":"pone.0339611.ref030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2741\/4443","article-title":"The PI3K\/AKT pathway in the pathogenesis of prostate cancer","volume":"21","author":"H Chen","year":"2016","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"3","key":"pone.0339611.ref031","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1464-410X.2007.07014.x","article-title":"Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men","volume":"100","author":"Y Shimizu","year":"2007","journal-title":"BJU Int."},{"issue":"1","key":"pone.0339611.ref032","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/s41467-020-16123-w","article-title":"Sequential Ras\/MAPK and PI3K\/AKT\/mTOR pathways recruitment drives basal extrusion in the prostate-like gland of Drosophila","volume":"11","author":"A Rambur","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"pone.0339611.ref033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/cbt.22627","article-title":"Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN\/Akt pathway in human esophageal squamous cell carcinoma cells","volume":"14","author":"Y Ou","year":"2013","journal-title":"Cancer Biol Ther."},{"issue":"6","key":"pone.0339611.ref034","first-page":"2161","article-title":"TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K\/Akt signaling pathway","volume":"44","author":"G Tang","year":"2019","journal-title":"Int J Mol Med."},{"issue":"1","key":"pone.0339611.ref035","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1038\/s41467-018-06606-2","article-title":"Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway","volume":"9","author":"S-H Shin","year":"2018","journal-title":"Nat Commun."},{"issue":"21","key":"pone.0339611.ref036","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.7150\/jca.46386","article-title":"Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma","volume":"11","author":"Y Wang","year":"2020","journal-title":"J Cancer."},{"key":"pone.0339611.ref037","first-page":"6927298","article-title":"Exogenous hydrogen sulfide regulates the growth of human thyroid carcinoma cells","volume":"2019","author":"D Wu","year":"2019","journal-title":"Oxid Med Cell Longev."}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T18:43:26Z","timestamp":1770057806000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339611"}},"subtitle":[],"editor":[{"given":"Deepak","family":"Shukla","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339611","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}